Clinical Trial Update: Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of hydroxychloroquine for recurrent pregnancy loss has been withdrawn. The study status on ClinicalTrials.gov indicates withdrawal of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Miscarriage
• Pregnancy Loss

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University of Utah | Conditions: Recurrent Pregnancy Loss, Miscarriage | Phase 2 | Status: WITHDRAWN